In this issue of Molecular Cell, Wan et al. (2018) uncover WIPI2 as a critical rheostat in the control of autophagic degradation by mTORC1 and demonstrate the physiological utility of this signaling axis in promoting the clearance of hepatic lipids.
Macroautophagy, hereafter termed autophagy, is an intracellular catabolic process involving the sequestration of cytosolic proteins and organelles into double-membrane vesicles, or autophagosomes, which are subsequently delivered to the lysosome for degradation. Due to the critical role of autophagy under homeostatic conditions across cell types as well as in diseases such as cancer, neurodegeneration, and aging, there is significant interest in identifying the key factors controlling the rate and specificity of autophagic degradation (Kroemer, 2015) . One of the first discovered upstream regulators of autophagy was the mammalian target of rapamycin complex 1 (mTORC1) (Yang and Klionsky, 2010) . mTORC1 integrates intracellular and extracellular signals to govern cell growth and metabolism and activation of this signaling axis inhibits autophagic degradation and recycling. In the current issue of Molecular Cell, Wan et al. (2018) identify WIPI2, a WD40domain-containing protein that functions as the mammalian ortholog of yeast Atg18, as a novel mTORC1 substrate that acts as a rheostat controlling the amplitude of autophagic induction downstream of mTORC1.
By integrating upstream signals, including nutrient levels, amino acid levels, and growth factor stimulation, mTORC1 directs whether cells grow and build biomass versus recycle cellular material through autophagy. Under nutrient-rich conditions, mTORC1 coordinately suppresses autophagy at several steps, including preventing autophagic membrane nucleation by the core autophagy machinery (i.e., ULK1, ATG13, and ATG14L), as well as by inhibiting both autophagosomal maturation and autolysosomal tubulation through the regulation of UVRAG (Chang and Neufeld, 2009; Kim et al., 2015; Yuan et al., 2013) . Furthermore, TFEB-mediated transcription of lysosomal and autophagosomal genes sustains autophagic responses under prolonged mTORC1 inhibition (Roczniak-Ferguson et al., 2012) . Upon nutrient starvation or inhibition of mTORC1, one can predict that the amplitude or intensity of autophagic degradation must be tuned to the particular needs and environment of the cell. Moreover, these signals that modulate the degree of autophagic flux may consequently influence the spectrum of substrates degraded by the autophagy pathway. Wan et al. (2018) identify mTORC1 phosphorylation of Serine 395 on WIPI2 as one such key signal. mTORC1 phosphorylation of WIPI2 governs the ability of the E3 ubiquitin ligase, HUWE1, to target WIPI2 for proteasomal degradation, thereby attenuating autophagy. Overall, by uncovering these previously unrecognized signaling mechanisms and post-translational modifications controlling WIPI2 protein stabilization, Wan et al. (2018) provide new molecular insight into how the levels of WIPI2 protein finetune autophagic flux in cells both in vitro and in vivo (Figure 1) .
By generating a site-specific phosphorylation-resistant WIPI2 mutant (WIPI2-S395A), Wan et al. (2018) uncouple the broader effects of mTORC1 on the core autophagy machinery from mTORC1-WIPI2-mediated control of autophagic intensity. Importantly, enforcing WIPI2-S395A expression enhances autophagic flux (Figure 1) . Remarkably, overexpressing wild-type WIPI2 is by itself sufficient to boost autophagic flux, indicating that increasing WIPI2 protein abundance can supersede mTORC1 and HUWE1 regulation of WIPI2. On the whole, these studies illuminate novel strategies to enhance autophagy and hence interrogate the cellular consequences of augmented autophagic catabolism in cells with sustained mTORC1 signaling, such as in cancer and other rapidly proliferating cells. Wan et al. (2018) demonstrate that WIPI2 localizes to both nascent autophagosomal structures and the lysosome (Figure 1 ). However, WIPI2 is not delivered to the lysosome via autophagy. Because the lysosomal localization of WIPI2 seems to precede interaction with and regulation by mTORC1, a deeper understanding of the signals controlling WIPI2 localization is required to fully parse out this signaling axis. Despite the similar affinity of WIPI2 for known autophagy machineries independent of mTORC1-mediated phosphorylation, there may be multiple pools of WIPI2 that are trafficked to distinct cellular compartments. Given the strong affinity of WIPI2 for phosphatidylinositol 4-phosphate (PI(4)P) and phosphatidylinositol 3-phosphate (PI(3)P), binding to these phospholipids likely affords additional layers of regulation governing WIPI2 localization, which merits further study. Moreover, it remains unclear whether mTORC1-phosphorylated WIPI2 functions in autophagosome biogenesis when HUWE1 is absent or limiting.
Mounting pre-clinical evidence suggests that inducing autophagy may be beneficial across a variety of disease states and during aging (Kroemer, 2015) . Notably, autophagy is critical for the degradation of pathogenic aggregates associated with Alzheimer's, Huntington's, and Parkinson's diseases, implying that enforced autophagy induction may ameliorate or even prevent these diseases (Ventruti and Cuervo, 2007) . Whereas decreased autophagic flux is frequently associated with aging, enforced autophagy induction via the knockin of a mutant form of the autophagy regulator Beclin1 (F121A) has been recently uncovered to extend both lifespan and healthspan (Ferná ndez et al., 2018) . As such, there is immense interest in identifying the key factors to enhance autophagic degradation for therapeutic purpose. However, it remains unclear whether particular modes of stimulating autophagy specify particular autophagic substrates and whether this impacts disease. Strikingly, Wan et al. (2018) demonstrate that WIPI2-mediated induction of autophagy not only degrades canonical autophagy substrates, but is also capable of driving lipid turnover in mouse livers, underscoring the potential utility of this approach in liver disease, such as in non-alcoholic steatohepatitis (NASH). Ascertaining how the mTORC1-WIPI2-HUWE1 axis impacts autophagy flux and cellular homeostasis in other physiological and disease situations remains an important topic for future study.
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Jayanta Debnath is a scientific advisory board member for Vescor Therapeutics, LLC. Canonical Autophagy Substrates Hepatic Lipids Other substrates?? Figure 1 . WIPI2 Phosphorylation by mTORC1 Mediates HUWE1-Dependent Ubiquitination and Proteasomal Degradation WIPI2 is phosphorylated by mTORC1 at Serine 395 (S395), allowing for HUWE1-mediated ubiquitination and proteasomal degradation of WIPI2, thus inhibiting the intensity of autophagy induction. The WIPI2-S395A mutant is resistant to phosphorylation by mTORC1 and enforces high levels of autophagic degradation of both canonical autophagy substrates and hepatic lipids even in nutrient-rich conditions.
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